University of Patras
Συσχέτιση της αδιπονεκτίνης με την απόπτωση και αυτοφαγία στον καρκίνο του ενδομητρίου
Abstract
dc:descriptionObesity is a well-established risk factor for endometrial cancer. Dysregulation and dysfunction of adipose-secreted hormones, known as adipokines, has been mechanistically linked to the development of malignancies. Adiponectin is the most abundant circulating adipokine and has antineoplastic and anti-inflammatory action. Low adiponectin levels have been reported in patients with obesity and have been associated with increased risk of endometrial cancer. Adiponectin acts on peripheral tissues via its two receptors AdipoR1 and AdipoR2. The expression of AdipoR1 and AdipoR2 in endometrial cancer is not established to date. The molecular mechanisms linking the low levels of adiponectin with development of endometrial cancer are yet to be elucidated. In this study, we examined the expression of AdipoR1 and AdipoR2 in ex vivo tissue preparations of human endometrial adenocarcinomas, and endometrial cancer cell lines in vitro. We investigated the role of AdipoRs in adiponectin signaling as well as the cellular signaling pathways mediating adiponectin’s antineoplastic action in endometrial cell lines. Furthermore, we evaluated the role of adiponectin in autophagy and apoptosis in endometrial cancer cell lines. Since oxidative stress has a significant role in the process of autophagy and apoptosis, we studied the effect of adiponectin on the formation of reactive oxygen species, as a marker of oxidative stress.In this study, we show that ex vivo preparations of human endometrial adenocarcinoma, and endometrial cancer cell lines in vitro express both AdipoR1 and AdipoR2. Adiponectin activates its intracellularly signaling pathways in endometrial cell lines directly by binding to AdipoRs, since administration of AdipoR1 and AdipoR2 siRNA inhibits adiponecting signaling. We then show that downregulation of LKB1 (a tumor-suppressive factor that acts via AMPK activation) prevents adiponectin-induced antineoplastic effects. Adiponectin administration reduces ERK 1/2 but not Akt phosphorylation in RL95-2 endometrial cancer cells that express PTEN while it inhibits activation of Akt but not ERK1/2 in KLE endometrial cancer cells that do not express PTEN. Adiponectin reduces cyclin D1 expression in KLE cells and cyclin E2 expression in RL95-2 cells. The adiponectin-induced reduction in cyclin D1 and cyclin E2 activity has a critical role in inhibition of endometrial cancer cell growth. Furthermore, we show that adiponectin promotes autophagy by increasing the protein levels of ATG5, Beclin-1 and LC3, and promoted apoptosis by reducing the levels of the anti-apoptotic protein Bcl-2. We last show that adiponectin results in increased production of reactive oxygen promoting autophagy and apoptosis. The results of this study are important because they promote the understanding of the mechanisms through which adiponectin exhibits its antineoplastic action and promotes autophagy in endometrial cancer. These results elucidate the molecular mechanisms linking obesity with endometrial cancer and may contribute to the development of novel therapeutic approaches.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Aronis, Konstantinos
- Αρώνης, Κωνσταντίνος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50464